Latest On Altimmune, Inc (ALT):
| Date/Time | Type | Description | Signal | Details |
|---|---|---|---|---|
| 2023-05-11 16:23 EST | News | Altimmune GAAP EPS of -$0.40 beats by $0.08 | N/A |  |
| 2023-05-11 16:22 EST | News | Altimmune, Inc. (ALT) Q1 2023 Earnings Call Transcript | N/A | |
| 2023-05-10 12:33 EST | News | Altimmune: A Story, It Seems, Of Too Little Too Late | N/A | |
| 2023-03-22 23:18 EST | News | Altimmune hits 10-month low as Goldman Sachs downgrades on weight loss data | N/A | |
| 2023-03-21 16:21 EST | News | Altimmune stock slumps ~35% amid phase 2 trial data of obesity drug pemvidutide | N/A | |
| 2023-03-21 16:20 EST | News | Altimmune leads obesity drug developers lower after data for lead asset | N/A | |
| 2023-02-28 16:09 EST | News | Altimmune GAAP EPS of -$0.43 beats by $0.11 | N/A | |
| 2023-02-28 16:07 EST | News | Altimmune (ALT) Q4 2022 Earnings Call Transcript | N/A | |
| 2023-02-28 01:16 EST | News | Altimmune Q4 2022 Earnings Preview | N/A | |
| 2023-02-23 11:31 EST | News | Altimmune's Peptide-Based Therapies Offer Substantial Opportunity | N/A | |
| 2023-02-21 21:15 EST | News | Altimmune: Potential Dual Action For Pemvidutide In Obesity, NASH | N/A | |
| 2022-12-21 01:07 EST | News | Altimmune rises 5% on positive data from phase 1 trial of Non-Alcoholic Fatty Liver Disease treatment | N/A | |
| 2022-12-02 18:36 EST | News | Altimmune Appears To Have A Winner, But Will The Market Believe? | N/A | |
| 2022-12-02 01:08 EST | News | Altimmune spikes as Goldman Sachs sees over 100% upside | N/A | |
| 2022-11-30 13:10 EST | News | Altimmune: Weight Loss Data Signals A Costly Confusion | N/A | |
| 2022-11-11 05:50 EST | News | Altimmune, Inc. (ALT) Q3 2022 Earnings Call Transcript | N/A | |
| 2022-11-10 12:39 EST | News | Altimmune GAAP EPS of -$0.48 beats by $0.01 | N/A | |
| 2022-11-10 12:38 EST | News | Altimmune rises 5.2% on smaller-than-expected Q3 loss | N/A | |
| 2022-09-16 22:56 EST | News | Altimmune defended at H.C. Wainwright ahead of key readout for obesity drug | N/A | |
| 2022-09-15 11:25 EST | News | Altimmune: Overreaction On NASH Data Creates Buying Opportunity | N/A | |
| 2022-09-14 18:07 EST | News | Altimmune stock slumps 56% despite drug meeting main goal of reducing liver fat in trial | N/A | |
| 2022-09-14 18:07 EST | News | Piper Sandler sees Altimmune liver/obesity drug competitive despite weight loss data | N/A | |
| 2022-09-07 13:52 EST | News | Reassessing Altimmune | N/A | |
| 2022-09-01 01:36 EST | News | Altimmune sets new 52-week high on rising volume | N/A | |
| 2022-08-11 22:36 EST | News | Altimmune GAAP EPS of -$0.42 beats by $0.05, revenue of $8K | N/A | |
| 2022-08-11 22:36 EST | News | Altimmune quarterly net loss narrows as it beats on the bottom line | N/A | |
| 2022-08-11 22:36 EST | News | Altimmune, Inc. (ALT) CEO Vipin Garg on Q2 2022 Results - Earnings Call Transcript | N/A | |
| 2022-08-11 05:48 EST | News | Altimmune Q2 2022 Earnings Preview | N/A | |
| 2022-06-29 11:28 EST | News | Altimmune: Several Catalysts In 2 Large Market Indications This Year | N/A | |
| 2022-05-13 06:49 EST | News | Altimmune, Inc. (ALT) CEO Vipin K. Garg on Q1 2022 Results - Earnings Call Transcript | N/A | |
| 2022-05-12 12:17 EST | News | Altimmune GAAP EPS of -$0.44 beats by $0.14, revenue of $0.03M misses by $0.85M | N/A | |
| 2022-05-11 18:31 EST | News | Altimmune Q1 2022 Earnings Preview | N/A | |
| 2022-04-07 19:53 EST | News | Altimmune's New Avatar As A Liver Disease Player | N/A | |
| 2022-04-01 18:50 EST | News | Altimmune begins enrollment in phase 2 trial of pemvidutide to treat obesity | N/A | |
| 2022-03-15 16:28 EST | News | Altimmune GAAP EPS of -$0.57 beats by $0.08, revenue of $3.28M beats by $3.19M | N/A | |
| 2022-03-15 16:28 EST | News | Altimmune stock falls ~5% despite Q4 beat | N/A | |
| 2022-03-15 16:28 EST | News | Altimmune, Inc. (ALT) CEO Vipin Garg on Q4 2021 Results - Earnings Call Transcript | N/A | |
| 2022-01-31 13:06 EST | News | FDA clears Altimmune's pemvidutide application for obesity | N/A | |
| 2022-01-03 16:07 EST | News | Altimmune: Changing Focus To Pemvidutide In 2022 | N/A | |
| 2021-12-13 14:56 EST | News | New finance chief at Altimmune | N/A | |
| 2021-11-23 16:46 EST | News | Warning: ALT is at high risk of performing badly | N/A | |
| 2021-11-22 18:32 EST | News | Altimmune (ALT) Presents At 2021 Virtual Healthcare Conference - Slideshow | N/A | |
| 2021-11-11 20:59 EST | News | Altimmune, Inc.'s (ALT) CEO Vipin Garg on Q3 2021 Results - Earnings Call Transcript | N/A | |
| 2021-11-11 00:44 EST | News | Altimmune EPS misses by $0.38, beats on revenue | N/A | |
| 2021-11-11 00:43 EST | News | Altimmune, Inc. (ALT) CEO Vipin Garg on Q3 2021 Results - Earnings Call Transcript | N/A | |
| 2021-11-10 02:01 EST | News | Altimmune Q3 2021 Earnings Preview | N/A | |
| 2021-10-16 20:22 EST | News | Altimmune: Changing The Thesis | N/A | |
| 2021-10-04 22:54 EST | News | Altimmune initiates Phase 1b trial of pemvidutide in non-alcoholic fatty liver disease | N/A | |
| 2021-09-28 11:25 EST | News | Altimmune spikes on data readout for obesity therapy tomorrow | N/A | |
| 2021-09-28 11:25 EST | News | Altimmune slips after posting 12-week data from Phase 1 trial for weight loss therapy | N/A | |
About Altimmune, Inc (ALT):
Altimmune, Inc., a clinical stage biopharmaceutical company, focuses on developing intranasal vaccines, immune modulating therapies, and treatments for liver disease. The company develops AdCOVID, a single-dose intranasal vaccine that is in Phase I clinical trial to protect against COVID-19; T-COVID, an intranasal immune modulating therapeutic candidate, which is in Phase I/II clinical trial to evaluate the potential of T-COVID to prevent clinical worsening in patients with early COVID-19; NasoShield, an anthrax vaccine product candidate that is in a Phase 1b trial; and NasoVAX, a recombinant intranasal vaccine product candidate, which completed Phase IIa clinical trial for the treatment of seasonal and pandemic use. It also focuses on developing ALT-801, a novel peptide-based dual GLP-1/glucagon receptor agonist for the treatment of non-alcoholic steatohepatitis that is in Phase I clinical trial; and HepTcell, an immunotherapeutic product candidate, which is in Phase II clinical trial for patients chronically infected with the hepatitis B virus. Altimmune, Inc. has a collaboration with the University of Alabama at Birmingham for the development of AdCOVID. The company is headquartered in Gaithersburg, Maryland.
General
- Name Altimmune, Inc
- Symbol ALT
- Type Common Stock
- Exchange NASDAQ
- Currency USD
- Country USA
- SectorHealthcare
- IndustryBiotechnology
- Full Time Employees 43
- Last Split Factor1:30
- Last Split Date2018-09-14
- Fiscal Year EndDecember
- IPO Date2005-10-06
- Gic SectorHealth Care
- Gic GroupPharmaceuticals, Biotechnology & Life Sciences
- Gic IndustryBiotechnology
- Gic SubIndustryBiotechnology
- Web URLhttp://altimmune.com
View More
Valuation
- Trailing PE 1.82
- Price/Sales (Trailing 12 Mt.) 54.44
- Price/Book (Most Recent Quarter) 2.86
- Enterprise Value Revenue 52.73
View More
Financials
- Most Recent Quarter 2020-12-31
- Current Year EPS Estimate -$2.04
- Next Year EPS Estimate $0.70
- Next Quarter EPS Estimate -$0.18
- Operating Margin -471%
- Return on Assets -16%
- Return on Equity -36%
- Revenue 8.19 million
- Earnings Per Share -$4.16
- Revenue Per Share $0.32
- Gross Profit -25324291
- Quarterly Earnings Growth 301.7%
View More
Highlights
- Market Capitalization 641.59 million
- EBITDA -11790191
- Analyst Target Price $41.83
- Book Value Per Share $6.11
View More
Share Statistics
- Shares Outstanding 37.15 million
- Shares Float 29.2 million
- % Held by Insiders 651%
- % Held by Institutions 67.3%
- Shares Short 2.41 million
- Shares Short Prior Month 2.52 million
- Short Ratio 1.22
- Short % of Float 8%
- Short % of Shares Outstanding 7%
View More
Technicals
- Beta 1.37
- 52 Week High $35.1
- 52 Week Low $2.68
- 50 Day Moving Average 17.82
- 200 Day Moving Average 13.78
View More
Dividends
- Dividend Date 2018-09-14
- ExDividend Date 2017-01-20
- Dividend Yield 0%
View More
Altimmune, Inc (ALT) Dividend Calendar:
ALT's last dividend payment was made to shareholders on September 14, 2018.
| Ex-Dividend Date | Payment Date | Record Date | Declared Date | Amount |
|---|
Altimmune, Inc (ALT) Earnings History:
Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.
| Quarter Date | Report Date | Actual Revenue | Reported EPS | EPS Estimate | Deviation from Estimate |
|---|---|---|---|---|---|
| 2020-12-31 | 2021-02-25 | $2.31 million | -$0.17 | -$0.80 | 78.84% |
| 2020-09-30 | 2020-11-09 | $2.94 million | -$0.54 | -$0.76 | 28.95% |
| 2020-06-30 | 2020-08-11 | $N/A | -$0.94 | -$0.29 | -229.82% |
| 2020-03-31 | 2020-05-13 | $2.21 million | -$0.26 | -$0.32 | 18.75% |
| 2019-12-31 | 2020-03-27 | $N/A | -$0.25 | -$0.26 | 3.85% |
| 2019-09-30 | 2019-11-13 | $643978 | -$0.74 | -$0.19 | -289.47% |
| 2019-06-30 | 2019-08-13 | $1.63 million | -$0.26 | -$0.25 | -4% |
| 2019-03-31 | 2019-04-01 | $2.96 million | -$0.27 | -$2.80 | 90.36% |
| 2018-12-31 | 2019-03-31 | $2.59 million | -$2.34 | -$2.80 | 16.43% |
| 2018-09-30 | 2018-11-13 | $2.63 million | -$1.73 | -$3.60 | 51.94% |
| 2018-06-30 | 2018-08-14 | $2.42 million | -$10.20 | -$4.50 | -126.67% |
| 2018-03-31 | 2018-05-15 | $2.69 million | -$8.73 | -$15.00 | 41.78% |
| 2017-12-31 | 2018-03-28 | $2.3 million | -$2.40 | -$15.00 | 84% |
| 2017-09-30 | 2017-11-09 | $4.59 million | -$10.20 | -$8.40 | -21.43% |
| 2017-06-30 | 2017-08-10 | $3.04 million | -$7.73 | ||
| 2014-09-30 | 2014-11-06 | $962451 | -$24.00 | -$7.50 | -220% |
| 2014-06-30 | 2014-08-04 | $3.66 million | -$3.00 | -$16.50 | 81.82% |
| 2014-03-31 | 2014-05-08 | $3.74 million | -$12.00 | -$18.00 | 33.33% |
| 2013-12-31 | 2014-03-11 | $3.65 million | -$24.00 | -$15.00 | -60% |
| 2013-09-30 | 2013-11-07 | $3.49 million | -$24.00 | -$10.50 | -128.57% |
| 2013-06-30 | 2013-08-07 | $4.3 million | -$6.00 | -$9.00 | 33.33% |
| 2013-03-31 | 2013-05-08 | $6.48 million | -$12.00 | -$15.00 | 20% |
| 2012-12-31 | 2013-03-13 | $6.01 million | -$6.00 | -$12.00 | 50% |
| 2012-09-30 | 2012-11-06 | $6.7 million | -$1.33 | -$9.00 | 85.25% |
| 2012-06-30 | 2012-08-07 | $6.32 million | -$6.00 | -$9.00 | 33.33% |
| 2012-03-31 | 2012-05-08 | $6.15 million | -$18.00 | -$15.00 | -20% |
| 2011-12-31 | 2012-03-08 | $3.00 | -$32.00 | 109.38% | |
| 2011-09-30 | 2011-11-09 | $5.26 million | -$0.21 | -$25.00 | 99.17% |
| 2011-06-30 | 2011-08-10 | $6.43 million | -$15.00 | -$31.50 | 52.38% |
| 2011-03-31 | 2011-05-11 | -$12.00 | -$29.00 | 58.62% | |
| 2010-12-31 | 2011-03-28 | -$138.00 | -$26.00 | -430.77% | |
| 2010-09-30 | 2010-11-11 | -$42.00 | -$52.00 | 19.23% | |
| 2010-06-30 | 2010-08-12 | -$66.00 | -$61.50 | -7.32% | |
| 2010-03-31 | 2010-05-11 | -$84.00 | -$51.00 | -64.71% | |
| 2009-12-31 | 2010-03-23 | -$60.00 | -$61.50 | 2.44% | |
| 2009-09-30 | 2009-11-12 | -$150.00 | -$57.00 | -163.16% | |
| 2009-06-30 | 2009-08-13 | -$72.00 | -$54.00 | -33.33% | |
| 2009-03-31 | 2009-05-15 | -$69.00 | -$60.00 | -15% | |
| 2008-12-31 | 2009-03-30 | -$51.00 | -$78.00 | 34.62% | |
| 2008-09-30 | 2008-11-13 | -$60.00 | -$78.00 | 23.08% | |
| 2008-06-30 | 2008-08-13 | -$296.82 | |||
| 2008-03-31 | 2008-05-14 | -$68.15 | |||
| 2007-09-30 | 2007-11-13 | -$20.56 | |||
| 2007-03-31 | 2007-03-31 | $7.48 | |||
| 2006-12-31 | 2006-12-31 | -$11,895.61 | |||
| 2006-09-30 | 2006-09-30 | $6.64 | |||
| 2006-06-30 | 2006-06-30 | $6.11 | |||
| 2006-03-31 | 2006-03-31 | $4.47 | |||
| 2005-12-31 | 2005-12-31 | $4.81 |
Altimmune, Inc (ALT) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
| Date |
|---|
| Research Development |
| Income Before Tax |
| Selling General Administrative |
| Gross Profit |
| Ebit |
| Operating Income |
| Income Tax Expense |
| Total Revenue |
| Cost of Revenue |
| Total Other Income Expense Net |
| Net Income From Continuing Operations |
| Net Income Applicable to Common Shares |
Cash Flow:
| Date |
|---|
| Investments |
| Change to Liabilities |
| Total Cash Flow from Investing Activities |
| Net Borrowings |
| Total Cash Flow from Financial Activities |
| Change to Operating Activities |
| Change in Cash |
| Total Cash from Operating Activities |
| Depreciation |
| Other Cash Flow from Investing Activities |
| Change to Inventory |
| Change to Account Receivables |
| Other Cash Flow from Financing Activities |
| Change to Net Income |
| Capital Expenditures |
Balance Sheet:
| Date |
|---|
| Total Liabailities |
| Total Stockholder Equity |
| Other Current Liabilities |
| Total Assets |
| Common Stock |
| Other Current Assets |
| Retained Earnings |
| Other Liabilities |
| Other Assets |
| Cash |
| Total Current Liabilities |
| Other Stockholder Equity |
| Property, Plant & Equipment |
| Total Current Assets |
| Long Term Investments |
| Net Tangible Assets |
| Short Term Investments |
| Long Term Debt |
| Inventory |
| Accounts Payable |
Altimmune, Inc (ALT) Chart:
Altimmune, Inc (ALT) News:
Below you will find a list of latest news for Altimmune, Inc (ALT) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
Altimmune, Inc (ALT) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
| Expiration Date | Strike | Last Price | Type | Volume | Open Interest | Implied Volatility | In The Money | Change | Change Percent |
|---|---|---|---|---|---|---|---|---|---|
| 2024-12-20 | 1 | 0 | CALL | 0 | 0 | 900.66 | TRUE | 0 | 0 |
| 2024-12-20 | 2 | 5 | CALL | 0 | 19 | 363.7 | TRUE | 0 | 0 |
| 2024-12-20 | 3 | 5.1 | CALL | 0 | 23 | 241.27 | TRUE | 0 | 0 |
| 2024-12-20 | 4 | 3.7 | CALL | 0 | 286 | 205.09 | TRUE | 0 | 0 |
| 2024-12-20 | 5 | 1.6 | CALL | 1 | 81 | 175.97 | TRUE | 1.6 | 0 |
| 2024-12-20 | 6 | 1.5 | CALL | 30 | 105 | 148.94 | TRUE | 0.22 | 0.17 |
| 2024-12-20 | 7 | 1.1 | CALL | 94 | 1584 | 162.05 | FALSE | 0.18 | 0.2 |
| 2024-12-20 | 8 | 0.7 | CALL | 8 | 819 | 143.96 | FALSE | 0.01 | 0.01 |
| 2024-12-20 | 9 | 0.45 | CALL | 11 | 488 | 145.13 | FALSE | -0.05 | -0.1 |
| 2024-12-20 | 10 | 0.36 | CALL | 0 | 386 | 147.54 | FALSE | 0 | 0 |
| 2024-12-20 | 11 | 0.34 | CALL | 0 | 295 | 146.55 | FALSE | 0 | 0 |
| 2024-12-20 | 12 | 0.27 | CALL | 0 | 181 | 145.83 | FALSE | 0 | 0 |
| 2024-12-20 | 13 | 0.3 | CALL | 0 | 142 | 146.46 | FALSE | 0 | 0 |
| 2024-12-20 | 14 | 0.28 | CALL | 0 | 469 | 149.67 | FALSE | 0 | 0 |
| 2024-12-20 | 15 | 0.15 | CALL | 5 | 566 | 146.62 | FALSE | -0.05 | -0.25 |
| 2024-12-20 | 1 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-12-20 | 2 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-12-20 | 3 | 0.24 | PUT | 0 | 36 | 0 | FALSE | 0 | 0 |
| 2024-12-20 | 4 | 0.21 | PUT | 0 | 51 | 73.58 | FALSE | 0 | 0 |
| 2024-12-20 | 5 | 0.5 | PUT | 0 | 147 | 62.25 | FALSE | 0 | 0 |
| 2024-12-20 | 6 | 1.14 | PUT | 12 | 267 | 34.31 | FALSE | 0.12 | 0.12 |
| 2024-12-20 | 7 | 1.63 | PUT | 0 | 230 | 0 | TRUE | 0 | 0 |
| 2024-12-20 | 8 | 2.05 | PUT | 0 | 59 | 0 | TRUE | 0 | 0 |
| 2024-12-20 | 9 | 2.86 | PUT | 0 | 25 | 0 | TRUE | 0 | 0 |
| 2024-12-20 | 10 | 3.46 | PUT | 0 | 527 | 0 | TRUE | 0 | 0 |
| 2024-12-20 | 11 | 0 | PUT | 0 | 0 | 0 | TRUE | 0 | 0 |
| 2024-12-20 | 12 | 5.7 | PUT | 0 | 3 | 158.36 | TRUE | 0 | 0 |
| 2024-12-20 | 13 | 6.75 | PUT | 0 | 2 | 182.59 | TRUE | 0 | 0 |
| 2024-12-20 | 14 | 0 | PUT | 0 | 0 | 0 | TRUE | 0 | 0 |
| 2024-12-20 | 15 | 0 | PUT | 0 | 0 | 260.74 | TRUE | 0 | 0 |
| 2025-01-17 | 1 | 6.84 | CALL | 0 | 3 | 0 | TRUE | 0 | 0 |
| 2025-01-17 | 2 | 0 | CALL | 0 | 0 | 327.96 | TRUE | 0 | 0 |
| 2025-01-17 | 3 | 3.61 | CALL | 14 | 2330 | 262.78 | TRUE | 3.61 | 0 |
| 2025-01-17 | 4 | 3.3 | CALL | 0 | 75 | 215.04 | TRUE | 0 | 0 |
| 2025-01-17 | 5 | 2.18 | CALL | 195 | 1145 | 194.03 | TRUE | 0.13 | 0.06 |
| 2025-01-17 | 6 | 1.35 | CALL | 3 | 252 | 178.18 | TRUE | -0.2 | -0.13 |
| 2025-01-17 | 7 | 1.35 | CALL | 931 | 2298 | 173.76 | FALSE | 0.1 | 0.08 |
| 2025-01-17 | 8 | 1.2 | CALL | 43 | 1898 | 179.61 | FALSE | 0.23 | 0.24 |
| 2025-01-17 | 9 | 0.9 | CALL | 15 | 650 | 167.74 | FALSE | 0.18 | 0.25 |
| 2025-01-17 | 10 | 0.77 | CALL | 42 | 7145 | 168.17 | FALSE | 0.16 | 0.26 |
| 2025-01-17 | 11 | 0.66 | CALL | 95 | 1110 | 168.08 | FALSE | 0.11 | 0.2 |
| 2025-01-17 | 12 | 0.7 | CALL | 0 | 400 | 168.54 | FALSE | 0 | 0 |
| 2025-01-17 | 13 | 0.5 | CALL | 1 | 1833 | 168.49 | FALSE | 0.07 | 0.16 |
| 2025-01-17 | 14 | 0.41 | CALL | 3 | 158 | 165.17 | FALSE | 0.41 | 0 |
| 2025-01-17 | 15 | 0.4 | CALL | 30 | 4009 | 170.31 | FALSE | 0.08 | 0.25 |
| 2025-01-17 | 17 | 0.24 | CALL | 10 | 491 | 174.96 | FALSE | 0.24 | 0 |
| 2025-01-17 | 20 | 0.25 | CALL | 308 | 9376 | 173.91 | FALSE | 0.06 | 0.32 |
| 2025-01-17 | 22 | 0.18 | CALL | 31 | 618 | 181.41 | FALSE | 0.18 | 0 |
| 2025-01-17 | 25 | 0.15 | CALL | 8 | 2869 | 186.98 | FALSE | 0.15 | 0 |
| 2025-01-17 | 27 | 0.1 | CALL | 0 | 661 | 188.16 | FALSE | 0 | 0 |
| 2025-01-17 | 30 | 0.25 | CALL | 0 | 2324 | 230.76 | FALSE | 0 | 0 |
| 2025-01-17 | 32 | 0.15 | CALL | 101 | 808 | 189.91 | FALSE | 0.05 | 0.5 |
| 2025-01-17 | 35 | 0.1 | CALL | 0 | 1444 | 215.87 | FALSE | 0 | 0 |
| 2025-01-17 | 40 | 0.05 | CALL | 0 | 3529 | 191.83 | FALSE | 0 | 0 |
| 2025-01-17 | 1 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2025-01-17 | 2 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2025-01-17 | 3 | 0.2 | PUT | 1 | 315 | 94.58 | FALSE | 0.2 | 0 |
| 2025-01-17 | 4 | 0.4 | PUT | 5 | 95 | 74.19 | FALSE | 0.4 | 0 |
| 2025-01-17 | 5 | 0.75 | PUT | 0 | 607 | 53.48 | FALSE | 0 | 0 |
| 2025-01-17 | 6 | 1.2 | PUT | 1 | 222 | 35.35 | FALSE | 0 | 0 |
| 2025-01-17 | 7 | 1.9 | PUT | 2 | 326 | 0 | TRUE | 1.9 | 0 |
| 2025-01-17 | 8 | 2.49 | PUT | 0 | 614 | 0 | TRUE | 0 | 0 |
| 2025-01-17 | 9 | 3.28 | PUT | 0 | 275 | 0 | TRUE | 0 | 0 |
| 2025-01-17 | 10 | 4.35 | PUT | 0 | 813 | 0 | TRUE | 0 | 0 |
| 2025-01-17 | 11 | 0 | PUT | 0 | 0 | 0 | TRUE | 0 | 0 |
| 2025-01-17 | 12 | 5.34 | PUT | 0 | 20 | 0 | TRUE | 0 | 0 |
| 2025-01-17 | 13 | 6.5 | PUT | 0 | 551 | 0 | TRUE | 0 | 0 |
| 2025-01-17 | 14 | 0 | PUT | 0 | 0 | 79.56 | TRUE | 0 | 0 |
| 2025-01-17 | 15 | 9.25 | PUT | 0 | 138 | 0 | TRUE | 0 | 0 |
| 2025-01-17 | 17 | 9.6 | PUT | 0 | 21 | 0 | TRUE | 0 | 0 |
| 2025-01-17 | 20 | 13.8 | PUT | 0 | 123 | 0 | TRUE | 0 | 0 |
| 2025-01-17 | 22 | 15.87 | PUT | 0 | 584 | 0 | TRUE | 0 | 0 |
| 2025-01-17 | 25 | 18.4 | PUT | 0 | 3 | 249.2 | TRUE | 0 | 0 |
| 2025-01-17 | 27 | 18.6 | PUT | 0 | 0 | 257.95 | TRUE | 0 | 0 |
| 2025-01-17 | 30 | 23.4 | PUT | 0 | 1 | 258.57 | TRUE | 0 | 0 |
| 2025-01-17 | 32 | 24.8 | PUT | 0 | 0 | 241.49 | TRUE | 0 | 0 |
| 2025-01-17 | 35 | 27.9 | PUT | 0 | 0 | 0 | TRUE | 0 | 0 |
| 2025-01-17 | 40 | 33.01 | PUT | 0 | 5 | 0 | TRUE | 0 | 0 |
| 2025-03-21 | 1 | 0 | CALL | 0 | 0 | 694.55 | TRUE | 0 | 0 |
| 2025-03-21 | 2 | 4.4 | CALL | 0 | 10 | 365.92 | TRUE | 0 | 0 |
| 2025-03-21 | 3 | 3.5 | CALL | 0 | 726 | 210.35 | TRUE | 0 | 0 |
| 2025-03-21 | 4 | 2.95 | CALL | 0 | 149 | 222.07 | TRUE | 0 | 0 |
| 2025-03-21 | 5 | 3 | CALL | 0 | 39 | 185.53 | TRUE | 0 | 0 |
| 2025-03-21 | 6 | 1.8 | CALL | 3 | 43 | 202.85 | TRUE | 1.8 | 0 |
| 2025-03-21 | 7 | 1.55 | CALL | 0 | 470 | 186.91 | FALSE | 0 | 0 |
| 2025-03-21 | 8 | 1.47 | CALL | 16 | 128 | 176.73 | FALSE | 1.47 | 0 |
| 2025-03-21 | 9 | 1.25 | CALL | 9 | 182 | 179.33 | FALSE | 0.1 | 0.09 |
| 2025-03-21 | 10 | 0.85 | CALL | 2 | 259 | 157.8 | FALSE | -0.03 | -0.03 |
| 2025-03-21 | 11 | 0.8 | CALL | 0 | 44 | 0 | FALSE | 0 | 0 |
| 2025-03-21 | 12 | 0.76 | CALL | 8 | 1256 | 166.48 | FALSE | 0.76 | 0 |
| 2025-03-21 | 13 | 0.65 | CALL | 3 | 1011 | 163.5 | FALSE | 0.06 | 0.1 |
| 2025-03-21 | 14 | 1.05 | CALL | 0 | 47 | 209.31 | FALSE | 0 | 0 |
| 2025-03-21 | 15 | 0.55 | CALL | 7 | 195 | 165.38 | FALSE | 0.05 | 0.1 |
| 2025-03-21 | 16 | 0.5 | CALL | 1 | 47 | 165.28 | FALSE | 0.5 | 0 |
| 2025-03-21 | 1 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2025-03-21 | 2 | 0.3 | PUT | 0 | 8 | 0 | FALSE | 0 | 0 |
| 2025-03-21 | 3 | 0.3 | PUT | 0 | 42 | 69.03 | FALSE | 0 | 0 |
| 2025-03-21 | 4 | 0.7 | PUT | 0 | 6 | 68.38 | FALSE | 0 | 0 |
| 2025-03-21 | 5 | 1 | PUT | 0 | 25 | 30.9 | FALSE | 0 | 0 |
| 2025-03-21 | 6 | 1.53 | PUT | 0 | 593 | 0 | FALSE | 0 | 0 |
| 2025-03-21 | 7 | 2.25 | PUT | 0 | 139 | 0 | TRUE | 0 | 0 |
| 2025-03-21 | 8 | 2.9 | PUT | 0 | 197 | 0 | TRUE | 0 | 0 |
| 2025-03-21 | 9 | 3.9 | PUT | 0 | 9 | 0 | TRUE | 0 | 0 |
| 2025-03-21 | 10 | 4.69 | PUT | 5 | 63 | 0 | TRUE | 0.2 | 0.04 |
| 2025-03-21 | 11 | 0 | PUT | 0 | 0 | 0 | TRUE | 0 | 0 |
| 2025-03-21 | 12 | 5.59 | PUT | 0 | 5 | 0 | TRUE | 0 | 0 |
| 2025-03-21 | 13 | 7.2 | PUT | 0 | 1 | 0 | TRUE | 0 | 0 |
| 2025-03-21 | 14 | 0 | PUT | 0 | 0 | 0 | TRUE | 0 | 0 |
| 2025-03-21 | 15 | 8.6 | PUT | 0 | 1 | 0 | TRUE | 0 | 0 |
| 2025-03-21 | 16 | 0 | PUT | 0 | 0 | 0 | TRUE | 0 | 0 |
| 2026-01-16 | 3 | 4.29 | CALL | 26 | 260 | 343.58 | TRUE | 0.48 | 0.13 |
| 2026-01-16 | 5 | 3.38 | CALL | 66 | 623 | 278.12 | TRUE | 0.28 | 0.09 |
| 2026-01-16 | 7 | 2.9 | CALL | 25 | 759 | 228.94 | FALSE | 0.35 | 0.14 |
| 2026-01-16 | 8 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2026-01-16 | 10 | 2 | CALL | 14 | 2719 | 217.91 | FALSE | 0.05 | 0.03 |
| 2026-01-16 | 12 | 1.9 | CALL | 7 | 162 | 222.38 | FALSE | 0.15 | 0.09 |
| 2026-01-16 | 15 | 1.52 | CALL | 79 | 2575 | 209.19 | FALSE | 0.12 | 0.09 |
| 2026-01-16 | 3 | 0.61 | PUT | 0 | 742 | 0 | FALSE | 0 | 0 |
| 2026-01-16 | 5 | 1.7 | PUT | 1 | 512 | 0 | FALSE | -0.05 | -0.03 |
| 2026-01-16 | 7 | 2.95 | PUT | 0 | 118 | 0 | TRUE | 0 | 0 |
| 2026-01-16 | 8 | 0 | PUT | 0 | 0 | 0 | TRUE | 0 | 0 |
| 2026-01-16 | 10 | 4.6 | PUT | 0 | 345 | 0 | TRUE | 0 | 0 |
| 2026-01-16 | 12 | 0 | PUT | 0 | 0 | 0 | TRUE | 0 | 0 |
| 2026-01-16 | 15 | 8.93 | PUT | 0 | 45 | 0 | TRUE | 0 | 0 |
| 2027-01-15 | 2 | 0 | CALL | 0 | 0 | 1006.17 | TRUE | 0 | 0 |
| 2027-01-15 | 3 | 4.8 | CALL | 70 | 0 | 476.94 | TRUE | 4.8 | 0 |
| 2027-01-15 | 4 | 0 | CALL | 0 | 0 | 397.61 | TRUE | 0 | 0 |
| 2027-01-15 | 5 | 0 | CALL | 0 | 0 | 368.18 | TRUE | 0 | 0 |
| 2027-01-15 | 7 | 3.6 | CALL | 6 | 7 | 332.85 | FALSE | 3.6 | 0 |
| 2027-01-15 | 10 | 3.25 | CALL | 0 | 343 | 298.25 | FALSE | 0 | 0 |
| 2027-01-15 | 12 | 2.96 | CALL | 0 | 3 | 286.17 | FALSE | 0 | 0 |
| 2027-01-15 | 15 | 2.25 | CALL | 0 | 44 | 266.04 | FALSE | 0 | 0 |
| 2027-01-15 | 2 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2027-01-15 | 3 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2027-01-15 | 4 | 1.34 | PUT | 0 | 1 | 0 | FALSE | 0 | 0 |
| 2027-01-15 | 5 | 2.4 | PUT | 1 | 1 | 0 | FALSE | 2.4 | 0 |
| 2027-01-15 | 7 | 3.46 | PUT | 0 | 13 | 0 | TRUE | 0 | 0 |
| 2027-01-15 | 10 | 5.4 | PUT | 0 | 2 | 0 | TRUE | 0 | 0 |
| 2027-01-15 | 12 | 0 | PUT | 0 | 0 | 0 | TRUE | 0 | 0 |
| 2027-01-15 | 15 | 0 | PUT | 0 | 0 | 0 | TRUE | 0 | 0 |
Latest ALT Trades:
| Date | Shares | Price |
|---|---|---|
| Jun 13, 2022 7:59 PM EST | 1 | $9.25 |
| Jun 13, 2022 7:59 PM EST | 399 | $9.25 |
| Jun 13, 2022 7:59 PM EST | 58 | $9.25 |
| Jun 13, 2022 7:59 PM EST | 100 | $9.25 |
| Jun 13, 2022 7:59 PM EST | 200 | $9.235 |
Altimmune, Inc (ALT) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
| Date | Form Type | Form Name | Link |
|---|---|---|---|
| 2020-07-01 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1326190/000089924320018161/0000899243-20-018161-index.htm |
| 2019-04-15 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1326190/000000000019007165/0000000000-19-007165-index.htm |
| 2019-08-16 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1326190/000000000019012559/0000000000-19-012559-index.htm |
| 2019-08-22 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1326190/000000000019012749/0000000000-19-012749-index.htm |
| 2019-06-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1326190/000089924319016650/0000899243-19-016650-index.htm |
| 2019-06-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1326190/000089924319017407/0000899243-19-017407-index.htm |
| 2019-09-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1326190/000089924319022846/0000899243-19-022846-index.htm |
| 2019-09-11 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1326190/000089924319023316/0000899243-19-023316-index.htm |
| 2019-09-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1326190/000089924319023318/0000899243-19-023318-index.htm |
| 2019-12-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1326190/000089924319028409/0000899243-19-028409-index.htm |
| 2020-01-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1326190/000089924320000074/0000899243-20-000074-index.htm |
| 2020-01-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1326190/000089924320000275/0000899243-20-000275-index.htm |
| 2020-01-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1326190/000089924320000276/0000899243-20-000276-index.htm |
| 2020-01-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1326190/000089924320000279/0000899243-20-000279-index.htm |
| 2020-01-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1326190/000089924320000286/0000899243-20-000286-index.htm |
| 2020-02-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1326190/000089924320002630/0000899243-20-002630-index.htm |
| 2020-02-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1326190/000089924320002960/0000899243-20-002960-index.htm |
| 2020-02-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1326190/000089924320002986/0000899243-20-002986-index.htm |
| 2020-02-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1326190/000089924320003006/0000899243-20-003006-index.htm |
| 2020-03-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1326190/000089924320006772/0000899243-20-006772-index.htm |
| 2020-04-01 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1326190/000089924320009897/0000899243-20-009897-index.htm |
| 2020-05-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1326190/000089924320011911/0000899243-20-011911-index.htm |
| 2020-05-12 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1326190/000089924320012836/0000899243-20-012836-index.htm |
| 2020-05-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1326190/000089924320012840/0000899243-20-012840-index.htm |
| 2020-05-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1326190/000089924320013395/0000899243-20-013395-index.htm |
| 2020-06-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1326190/000089924320014937/0000899243-20-014937-index.htm |
| 2020-06-29 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1326190/000089924320017823/0000899243-20-017823-index.htm |
| 2020-06-29 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1326190/000089924320017824/0000899243-20-017824-index.htm |
| 2020-06-29 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1326190/000089924320017826/0000899243-20-017826-index.htm |
| 2020-06-29 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1326190/000089924320017831/0000899243-20-017831-index.htm |
| 2020-06-29 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1326190/000089924320017833/0000899243-20-017833-index.htm |
| 2020-06-29 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1326190/000089924320017835/0000899243-20-017835-index.htm |
| 2020-07-01 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1326190/000089924320018161/0000899243-20-018161-index.htm |
| 2020-08-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1326190/000089924320021020/0000899243-20-021020-index.htm |
| 2020-08-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1326190/000089924320021205/0000899243-20-021205-index.htm |
| 2020-08-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1326190/000089924320021207/0000899243-20-021207-index.htm |
| 2020-08-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1326190/000089924320021212/0000899243-20-021212-index.htm |
| 2020-08-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1326190/000089924320021219/0000899243-20-021219-index.htm |
| 2020-08-31 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1326190/000089924320023683/0000899243-20-023683-index.htm |
| 2020-09-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1326190/000089924320026409/0000899243-20-026409-index.htm |
| 2020-09-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1326190/000089924320026410/0000899243-20-026410-index.htm |
| 2020-09-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1326190/000089924320026411/0000899243-20-026411-index.htm |
| 2020-09-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1326190/000089924320026412/0000899243-20-026412-index.htm |
| 2020-09-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1326190/000089924320026413/0000899243-20-026413-index.htm |
| 2020-09-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1326190/000089924320026414/0000899243-20-026414-index.htm |
| 2020-09-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1326190/000089924320026415/0000899243-20-026415-index.htm |
| 2020-10-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1326190/000089924320026921/0000899243-20-026921-index.htm |
| 2020-10-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1326190/000089924320028535/0000899243-20-028535-index.htm |
| 2020-10-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1326190/000089924320028536/0000899243-20-028536-index.htm |
| 2020-10-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1326190/000089924320028537/0000899243-20-028537-index.htm |
| 2020-10-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1326190/000089924320028538/0000899243-20-028538-index.htm |
| 2020-10-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1326190/000089924320028539/0000899243-20-028539-index.htm |
| 2020-10-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1326190/000089924320028540/0000899243-20-028540-index.htm |
| 2020-11-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1326190/000089924320030113/0000899243-20-030113-index.htm |
| 2019-03-27 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1326190/000092542119000135/0000925421-19-000135-index.htm |
| 2019-03-27 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1326190/000092542119000137/0000925421-19-000137-index.htm |
| 2018-09-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1326190/000101297518001065/0001012975-18-001065-index.htm |
| 2018-10-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1326190/000101297518001091/0001012975-18-001091-index.htm |
| 2018-10-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1326190/000101297518001100/0001012975-18-001100-index.htm |
| 2018-12-04 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1326190/000101297518001271/0001012975-18-001271-index.htm |
| 2018-12-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1326190/000101297518001273/0001012975-18-001273-index.htm |
| 2019-01-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1326190/000101297519000028/0001012975-19-000028-index.htm |
| 2019-01-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1326190/000101297519000029/0001012975-19-000029-index.htm |
| 2019-01-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1326190/000101297519000031/0001012975-19-000031-index.htm |
| 2019-01-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1326190/000101297519000033/0001012975-19-000033-index.htm |
| 2019-01-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1326190/000101297519000035/0001012975-19-000035-index.htm |
| 2019-01-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1326190/000101297519000037/0001012975-19-000037-index.htm |
| 2019-01-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1326190/000101297519000039/0001012975-19-000039-index.htm |
| 2019-01-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1326190/000101297519000041/0001012975-19-000041-index.htm |
| 2019-01-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1326190/000101297519000043/0001012975-19-000043-index.htm |
| 2020-02-14 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1326190/000106823820000055/0001068238-20-000055-index.htm |
| 2018-10-05 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1326190/000110465918060692/0001104659-18-060692-index.htm |
| 2019-02-05 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1326190/000110465919005825/0001104659-19-005825-index.htm |
| 2019-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1326190/000110465919008563/0001104659-19-008563-index.htm |
| 2020-06-01 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1326190/000110465920068336/0001104659-20-068336-index.htm |
| 2020-06-25 | SC 13D | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1326190/000110465920076855/0001104659-20-076855-index.htm |
| 2020-09-24 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1326190/000110465920108310/0001104659-20-108310-index.htm |
| 2020-10-05 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1326190/000110465920112175/0001104659-20-112175-index.htm |
| 2018-09-24 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1326190/000119312518280602/0001193125-18-280602-index.htm |
| 2018-09-24 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1326190/000119312518280966/0001193125-18-280966-index.htm |
| 2018-09-25 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1326190/000119312518281668/0001193125-18-281668-index.htm |
| 2018-09-26 | S-1/A | General form for registration of securities under the Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/1326190/000119312518284095/0001193125-18-284095-index.htm |
| 2018-09-27 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1326190/000119312518285764/0001193125-18-285764-index.htm |
| 2018-09-27 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1326190/000119312518285783/0001193125-18-285783-index.htm |
| 2018-09-28 | POS EX | Post-effective amendment adding exhibits to registration statement [Rule 462(d)] | https://www.sec.gov/Archives/edgar/data/1326190/000119312518286447/0001193125-18-286447-index.htm |
| 2018-10-01 | 424B4 | Prospectus [Rule 424(b)(4)] | https://www.sec.gov/Archives/edgar/data/1326190/000119312518289729/0001193125-18-289729-index.htm |
| 2018-10-01 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1326190/000119312518289763/0001193125-18-289763-index.htm |
| 2018-10-04 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1326190/000119312518293265/0001193125-18-293265-index.htm |
| 2018-10-09 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1326190/000119312518295412/0001193125-18-295412-index.htm |
| 2018-10-09 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1326190/000119312518295424/0001193125-18-295424-index.htm |
| 2018-10-09 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1326190/000119312518296082/0001193125-18-296082-index.htm |
| 2018-10-22 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1326190/000119312518304261/0001193125-18-304261-index.htm |
| 2018-11-13 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1326190/000119312518325584/0001193125-18-325584-index.htm |
| 2018-11-13 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1326190/000119312518325587/0001193125-18-325587-index.htm |
| 2018-11-27 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1326190/000119312518335258/0001193125-18-335258-index.htm |
| 2018-11-30 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1326190/000119312518339667/0001193125-18-339667-index.htm |
| 2018-11-30 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1326190/000119312518339756/0001193125-18-339756-index.htm |
| 2018-12-03 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1326190/000119312518340078/0001193125-18-340078-index.htm |
| 2019-02-11 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1326190/000119312519033928/0001193125-19-033928-index.htm |
| 2019-03-08 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1326190/000119312519067835/0001193125-19-067835-index.htm |
| 2019-03-11 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1326190/000119312519070141/0001193125-19-070141-index.htm |
| 2019-03-11 | 424B2 | Prospectus [Rule 424(b)(2)] | https://www.sec.gov/Archives/edgar/data/1326190/000119312519070146/0001193125-19-070146-index.htm |
| 2019-03-15 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1326190/000119312519076851/0001193125-19-076851-index.htm |
| 2019-04-04 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1326190/000119312519097986/0001193125-19-097986-index.htm |
| 2019-04-04 | S-3 | Registration statement under Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/1326190/000119312519097996/0001193125-19-097996-index.htm |
| 2019-04-11 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1326190/000119312519103831/0001193125-19-103831-index.htm |
| 2019-04-11 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1326190/000119312519104131/0001193125-19-104131-index.htm |
| 2019-06-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1326190/000119312519168149/0001193125-19-168149-index.htm |
| 2019-06-12 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1326190/000119312519171212/0001193125-19-171212-index.htm |
| 2019-06-21 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1326190/000119312519178904/0001193125-19-178904-index.htm |
| 2019-07-09 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1326190/000119312519190926/0001193125-19-190926-index.htm |
| 2019-07-15 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1326190/000119312519193586/0001193125-19-193586-index.htm |
| 2019-08-09 | PRE 14A | Other preliminary proxy statements | https://www.sec.gov/Archives/edgar/data/1326190/000119312519218069/0001193125-19-218069-index.htm |
| 2019-08-14 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1326190/000119312519221188/0001193125-19-221188-index.htm |
| 2019-08-19 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1326190/000119312519224352/0001193125-19-224352-index.htm |
| 2019-08-19 | PRER14A | Preliminary Proxy Soliciting materials | https://www.sec.gov/Archives/edgar/data/1326190/000119312519224357/0001193125-19-224357-index.htm |
| 2019-08-21 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1326190/000119312519225595/0001193125-19-225595-index.htm |
| 2019-08-22 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1326190/000119312519226618/0001193125-19-226618-index.htm |
| 2019-10-01 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1326190/000119312519259847/0001193125-19-259847-index.htm |
| 2020-03-27 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1326190/000119312520087649/0001193125-20-087649-index.htm |
| 2020-03-27 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1326190/000119312520088680/0001193125-20-088680-index.htm |
| 2020-04-08 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1326190/000119312520100902/0001193125-20-100902-index.htm |
| 2020-05-12 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1326190/000119312520139801/0001193125-20-139801-index.htm |
| 2020-06-01 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1326190/000119312520156447/0001193125-20-156447-index.htm |
| 2020-06-01 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1326190/000119312520156472/0001193125-20-156472-index.htm |
| 2020-07-13 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1326190/000119312520191485/0001193125-20-191485-index.htm |
| 2020-07-13 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1326190/000119312520191866/0001193125-20-191866-index.htm |
| 2020-07-15 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1326190/000119312520192791/0001193125-20-192791-index.htm |
| 2020-07-16 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1326190/000119312520194024/0001193125-20-194024-index.htm |
| 2020-07-16 | 8-K/A | Current report | https://www.sec.gov/Archives/edgar/data/1326190/000119312520194052/0001193125-20-194052-index.htm |
| 2020-08-21 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1326190/000119312520226963/0001193125-20-226963-index.htm |
| 2020-08-21 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1326190/000119312520226971/0001193125-20-226971-index.htm |
| 2020-09-25 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1326190/000119312520254566/0001193125-20-254566-index.htm |
| 2020-02-14 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1326190/000120919120009672/0001209191-20-009672-index.htm |
| 2018-10-17 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1326190/000121390018014006/0001213900-18-014006-index.htm |
| 2019-02-08 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1326190/000121390019001904/0001213900-19-001904-index.htm |
| 2020-02-11 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1326190/000121390020003212/0001213900-20-003212-index.htm |
| 2019-02-01 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1326190/000139382519000035/0001393825-19-000035-index.htm |
| 2020-01-31 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1326190/000139382520000012/0001393825-20-000012-index.htm |
| 2019-04-01 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1326190/000156459019010429/0001564590-19-010429-index.htm |
| 2019-04-01 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1326190/000156459019010435/0001564590-19-010435-index.htm |
| 2019-05-14 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1326190/000156459019019139/0001564590-19-019139-index.htm |
| 2019-05-14 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1326190/000156459019019146/0001564590-19-019146-index.htm |
| 2019-08-13 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1326190/000156459019031795/0001564590-19-031795-index.htm |
| 2019-08-13 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1326190/000156459019031811/0001564590-19-031811-index.htm |
| 2019-11-13 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1326190/000156459019043231/0001564590-19-043231-index.htm |
| 2019-11-13 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1326190/000156459019043240/0001564590-19-043240-index.htm |
| 2020-03-27 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1326190/000156459020013376/0001564590-20-013376-index.htm |
| 2020-03-27 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1326190/000156459020013377/0001564590-20-013377-index.htm |
| 2020-05-13 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1326190/000156459020025123/0001564590-20-025123-index.htm |
| 2020-05-13 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1326190/000156459020025137/0001564590-20-025137-index.htm |
| 2020-08-11 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1326190/000156459020039298/0001564590-20-039298-index.htm |
| 2020-08-11 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1326190/000156459020039314/0001564590-20-039314-index.htm |
| 2020-05-28 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1326190/000173804820000001/0001738048-20-000001-index.htm |
| 2020-05-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1326190/000173804820000002/0001738048-20-000002-index.htm |
| 2020-06-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1326190/000173804820000003/0001738048-20-000003-index.htm |
| 2018-09-27 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/1326190/999999999518002478/9999999995-18-002478-index.htm |
| 2019-04-12 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/1326190/999999999519000701/9999999995-19-000701-index.htm |
| 2018-10-04 | CT ORDER | Confidential treatment order | https://www.sec.gov/Archives/edgar/data/1326190/999999999718008376/9999999997-18-008376-index.htm |
Altimmune, Inc (ALT) Insider Transactions:
Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Altimmune, Inc (ALT). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.Insider Ownership: 651%Institutional Ownership: 6730%
| Transaction Date | Insider Name | Insider Title | Type | Shares Number | Shares Price | Total Transaction | Shares Held After Transaction | Link |
|---|---|---|---|---|---|---|---|---|
| 2020-07-31 | William Michael Brown | Chief Financial Officer | Buy | 7,920.00 | 1.46 | 11,563.20 | 15,981.00 | https://www.sec.gov/Archives/edgar/data/1326190/000089924320021212/0000899243-20-021212-index.htm |
| 2020-05-15 | VELOCITY PHARMACEUTICAL HOLDINGS LLC | 10% Share Holder | Sell | 30,622.00 | 4.65 | 142,392.30 | 1,687,250.00 | https://www.sec.gov/Archives/edgar/data/1326190/000089924320013395/0000899243-20-013395-index.htm |
| 2020-05-14 | VELOCITY PHARMACEUTICAL HOLDINGS LLC | 10% Share Holder | Sell | 169,378.00 | 4.81 | 814,708.18 | 1,717,872.00 | https://www.sec.gov/Archives/edgar/data/1326190/000089924320013395/0000899243-20-013395-index.htm |
| 2018-10-09 | Wayne Pisano | Director | Buy | 2,000.00 | 4.59 | 9,180.00 | 2,000.00 | https://www.sec.gov/Archives/edgar/data/1326190/000101297518001100/0001012975-18-001100-index.htm |
| 2020-05-26 | Venrock Healthcare Capital Partners III, L.P. | 10% Share Holder | Buy | 309,453.00 | 8.79 | 2,720,091.87 | 2,005,817.00 | https://www.sec.gov/Archives/edgar/data/1326190/000173804820000002/0001738048-20-000002-index.htm |
| 2020-05-26 | Venrock Healthcare Capital Partners III, L.P. | 10% Share Holder | Buy | 390,547.00 | 9.78 | 3,819,549.66 | 2,396,364.00 | https://www.sec.gov/Archives/edgar/data/1326190/000173804820000002/0001738048-20-000002-index.htm |
| 2020-05-27 | Venrock Healthcare Capital Partners III, L.P. | 10% Share Holder | Buy | 125,162.00 | 7.23 | 904,921.26 | 2,521,526.00 | https://www.sec.gov/Archives/edgar/data/1326190/000173804820000002/0001738048-20-000002-index.htm |
| 2020-05-27 | Venrock Healthcare Capital Partners III, L.P. | 10% Share Holder | Buy | 277,000.00 | 7.92 | 2,193,840.00 | 2,798,526.00 | https://www.sec.gov/Archives/edgar/data/1326190/000173804820000002/0001738048-20-000002-index.htm |
| 2020-05-28 | Venrock Healthcare Capital Partners III, L.P. | 10% Share Holder | Buy | 27,763.00 | 7.79 | 216,273.77 | 2,826,289.00 | https://www.sec.gov/Archives/edgar/data/1326190/000173804820000002/0001738048-20-000002-index.htm |
| 2020-05-28 | Venrock Healthcare Capital Partners III, L.P. | 10% Share Holder | Buy | 173,711.00 | 8.87 | 1,540,816.57 | 3,000,000.00 | https://www.sec.gov/Archives/edgar/data/1326190/000173804820000002/0001738048-20-000002-index.htm |
| 2018-11-30 | Vipin K Garg | President and CEO | Buy | 322,907.00 | 322,907.00 | https://www.sec.gov/Archives/edgar/data/1326190/000101297518001273/0001012975-18-001273-index.htm | ||
| 2020-07-31 | Vipin K Garg | Chief Financial Officer | Buy | 11,674.00 | 1.46 | 17,044.04 | 325,789.00 | https://www.sec.gov/Archives/edgar/data/1326190/000089924320021205/0000899243-20-021205-index.htm |
| 2020-01-31 | Vipin K Garg | President and CEO | Buy | 11,289.00 | 1.46 | 16,481.94 | 326,206.00 | https://www.sec.gov/Archives/edgar/data/1326190/000089924320002986/0000899243-20-002986-index.htm |
| 2019-09-05 | Vipin K Garg | President and CEO | Buy | 20,000.00 | 2.10 | 42,000.00 | 342,907.00 | https://www.sec.gov/Archives/edgar/data/1326190/000089924319022846/0000899243-19-022846-index.htm |
| 2020-06-15 | Venrock Healthcare Capital Partners III, L.P. | 10% Share Holder | Buy | 1,500,000.00 | 7.54 | 11,310,000.00 | 4,500,000.00 | https://www.sec.gov/Archives/edgar/data/1326190/000173804820000003/0001738048-20-000003-index.htm |
| 2020-01-31 | M Scot Roberts | Chief Scientific Officer | Buy | 3,698.00 | 1.46 | 5,399.08 | 5,535.00 | https://www.sec.gov/Archives/edgar/data/1326190/000089924320002960/0000899243-20-002960-index.htm |
| 2020-01-31 | William Michael Brown | Chief Financial Officer | Buy | 8,061.00 | 1.46 | 11,769.06 | 8,061.00 | https://www.sec.gov/Archives/edgar/data/1326190/000089924320003006/0000899243-20-003006-index.htm |
| 2020-07-31 | Matthew Scott Harris | Chief Medical Officer | Buy | 8,084.00 | 1.46 | 11,802.64 | 8,084.00 | https://www.sec.gov/Archives/edgar/data/1326190/000089924320021219/0000899243-20-021219-index.htm |
| 2020-07-31 | M Scot Roberts | Chief Scientific Officer | Buy | 3,859.00 | 1.46 | 5,634.14 | 9,394.00 | https://www.sec.gov/Archives/edgar/data/1326190/000089924320021207/0000899243-20-021207-index.htm |